Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, VET, TRI, MAT, DEI

Introducing The Evolution of CBD Retail


SHERIDAN, Wyo., May 24, 2022 /PRNewswire/ -- We're excited to introduce an evolutionary step in CBD sales with www.gonzogummies.com. Over the last 3 years as CBD has exploded in popularity consumers are faced with either a more expensive in-store experience which was designed to provide an educational format for newcomers, or an innumerable selection of online sources, with very little ability to decipher the reputation and quality or gain any sort of guidance based on individual needs.

Gonzo Gummies has partnered with several reputable high-end manufacturers, as well as a dedicated staff of CBD specialists to provide the best of both worlds. This next step in CBD allows consumers to experience a wealth of innovative CBD products, including Delta 8, Delta 10, THCO, THCV, THCP and HHC along with easy access to guidance and support from specialists from every category of use. Gonzo Gummies is committed to expanding the awareness and use across the country as well with products that align with current cannabis formats, such as disposable vapes, wax (dabs) products and edibles that may provide a higher potency as well as benefits that may be a closer resemblance to traditional cannabis products.

With everything from top shelf Delta 8/THCO flower to large rechargeable disposable vapes, as well as impeccable easy to access lab reporting that allows the consumer to ensure they aren't putting anything harmful to their body; Gonzo Gummies is at the forefront of the CBD Revolution. Constant innovation paired with some of the most reasonable pricing in the industry as well as incredibly fast shipping will provide nation-wide access to better quality of life products for those just delving into CBD as well as the long-time consumer.

A full selection of products is available now at www.gonzogummies.com now. A number of communication options are readily accessible on this same site as well, allowing the general public better access to CBD specialists within 12 hours of initial correspondence, 7 days a week.

About Gonzo Gummies: Gonzo Gummies was founded in order to provide quality of life products that meet Federal requirements while also accommodating the needs of a wider range of consumer who may be looking for more than the traditional hemp-based products found currently. The goal was also to provide more visibility to consumers in order to expand education and awareness in hopes of a broader acceptance.

SOURCE Gonzo Gummies LLC


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: